Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-18

FDA Approved: TEMAZEPAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for temazepam submitted by Actavis Pharma, Inc., under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temazepam (Temazepam)

Snippet

SUPPL AP for TEMAZEPAM (TEMAZEPAM)